Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by DaveInCalgaryon Feb 17, 2024 12:55am
286 Views
Post# 35885554

Tilray Brands - German Cannabis Legalization Update

Tilray Brands - German Cannabis Legalization Update
How big is Germany's medical cannabis market?

According to Prohibition Partners, Germany represents half of Europe's medical cannabis market, with 2023 sales of approximately €390 million ($427 million) to over 230,000 patients. Dec 29, 2023

NOTE: Current German Medical Cannabis Market requires DRs prescriptions as well as a narcotics prescription, that has to be updated and re-prescribed with regular Drs office visits. 
Medical Cannabis is covered by German Health Insurance.
97% of Germans have Health Insurance.

https://businessofcannabis.com/germany-publishes-draft-law-for-pillar-1-confirming-plans-to-declassify-cannabis-as-a-narcotic/

Under new law April 1, 2024 -  Medical Cannabis

 "Medical cannabis should be legally clearly separated from cannabis for non-medical purposes. Medical cannabis is therefore not regulated in the Cannabis Act, but in a separate Medical Cannabis Act. The content of the existing regulations on medical cannabis remains essentially unchanged. Medical cannabis may continue to be prescribed as a medicine in accordance with the applicable social law requirements. However, a prescription for a special narcotic prescription will no longer be necessary in the future. A regular recipe is sufficient here." (One step above 'over the counter')

Bloomwell CEO has predicted German Medical Cannabis Prescriptions will increase 10 fold within 12 months.

Curaleaf CEO predicts German Medical Cannabis will grow within 18 months to be 4 times larger than Florida's Medical Cannabis market.

Medical Cannabis is a fast growing business

 
<< Previous
Bullboard Posts
Next >>